Software
IndustriesManufacturerWaters
Importance of the Topic
The management of electronic records and compliance with 21 CFR Part 11 and EU Annex 11 is critical for regulated laboratories in the pharmaceutical and biotechnology industries. These regulations ensure data integrity, trustworthiness, and reliability of electronic records and signatures. Adapting to an electronic-records environment improves efficiency and safeguards against data manipulation.
Objectives and Study Overview
This white paper reviews how Waters Empower Chromatography Data System supports compliance with electronic records regulations. It outlines the technical controls built into Empower to meet requirements such as record creation, audit trails, secure storage, access control, and electronic signature implementation for 21 CFR Part 11 and EU Annex 11.
Methodology and Instrumentation
Empower is a client-server solution built on an Oracle relational database. It integrates with controlled instruments, including:
- HPLC and UPLC systems
- GC and GC-MS instruments
- Mass spectrometers (MS) and spectrophotometers (UV)
- Convertors (SAT/IN) for analog signals
- Laboratory information tools (LIMS, ELNs, SDMS)
Key Results and Discussion
Empower delivers a suite of technical controls required by Part 11 for closed systems:
- Accurate, complete copies of electronic records with human- and machine-readable formats
- Secure data archiving and rapid retrieval throughout retention periods
- Automated backup and restore of live GxP records and entire projects
- Enforced user authentication, password policies, and privilege-based access control
- Device checks and validation of instrument drivers
- Comprehensive, tamper-evident, time-stamped audit trails for system, project, method, and result changes
- Non-biometric electronic signature support with username/password combinations, signature manifestations, and permanent record linkage
Benefits and Practical Applications
Empower simplifies compliance by embedding necessary controls and providing transparent documentation for audits. Laboratories can:
- Reduce reliance on paper records and manual processes
- Ensure regulatory readiness with clear validation and qualification records
- Facilitate rapid response to inspections with electronic data access
- Improve data security and governance across enterprise deployments
Future Trends and Potential Applications
The progression toward fully electronic workflows will continue, driven by global regulators. Emerging trends include:
- Integration with cloud-based data platforms and laboratory information management systems
- Advanced encryption and blockchain for open system transmissions
- Enhanced AI-driven audit trail analysis and anomaly detection
- Digital signature advancements, including biometric methods
Conclusion
Waters Empower provides a robust framework to manage chromatography data in compliance with 21 CFR Part 11 and Annex 11. Its comprehensive controls for record integrity, secure storage, access management, and electronic signatures help laboratories maintain trustworthy data and reduce compliance risks.
Reference
- FDA. Title 21 CFR Part 11. Code of Federal Regulations. Effective 1997.
- European Commission. EudraLex Volume 4 Annex 11. Good Manufacturing Practice, 2011.
- FDA. Guidance: Records and Reports; Level 2 Guidance for FDA Staff, 2010.
- FDA. Data Integrity and CGMP Guidance for Industry (Draft), 2016.
- MHRA. GxP Data Integrity Definitions and Guidance, 2018.
- OECD. GLP Principles No. 17: Applications to Computerized Systems, 2017.
- FDA. Electronic Records and Electronic Signatures Compliance Policy Guide, 1999.
- WHO. Good Data and Record Management Practices, 2016.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.